These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1600 related items for PubMed ID: 20055750

  • 1. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
    Stein GE, Wells EM.
    Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
    [Abstract] [Full Text] [Related]

  • 2. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.
    Maclayton DO, Hall RG.
    Ann Pharmacother; 2007 Feb; 41(2):235-44. PubMed ID: 17299012
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis.
    Bounthavong M, Hsu DI.
    Curr Med Res Opin; 2010 Feb; 26(2):407-21. PubMed ID: 20001574
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus.
    Itani KM, Dryden MS, Bhattacharyya H, Kunkel MJ, Baruch AM, Weigelt JA.
    Am J Surg; 2010 Jun; 199(6):804-16. PubMed ID: 20227056
    [Abstract] [Full Text] [Related]

  • 5. Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
    Lin DF, Zhang YY, Wu JF, Wang F, Zheng JC, Miao JZ, Zheng LY, Sheng RY, Zhou X, Shen HH, Ijzerman MM, Croos-Dabrera RV, Sheng W.
    Int J Antimicrob Agents; 2008 Sep; 32(3):241-9. PubMed ID: 18635341
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.
    McKinnon PS, Sorensen SV, Liu LZ, Itani KM.
    Ann Pharmacother; 2006 Jun; 40(6):1017-23. PubMed ID: 16720705
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Stevens DL, Herr D, Lampiris H, Hunt JL, Batts DH, Hafkin B.
    Clin Infect Dis; 2002 Jun 01; 34(11):1481-90. PubMed ID: 12015695
    [Abstract] [Full Text] [Related]

  • 13. Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections.
    Stein GE, Schooley S, Peloquin CA, Missavage A, Havlichek DH.
    J Antimicrob Chemother; 2007 Oct 01; 60(4):819-23. PubMed ID: 17673476
    [Abstract] [Full Text] [Related]

  • 14. Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Puzniak LA, Morrow LE, Huang DB, Barreto JN.
    Clin Ther; 2013 Oct 01; 35(10):1557-70. PubMed ID: 24011955
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children.
    Kaplan SL, Afghani B, Lopez P, Wu E, Fleishaker D, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB.
    Pediatr Infect Dis J; 2003 Sep 01; 22(9 Suppl):S178-85. PubMed ID: 14520144
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of linezolid versus vancomycin for hospitalised patients with complicated skin and soft-tissue infections in Germany.
    Schürmann D, Sorensen SV, De Cock E, Duttagupta S, Resch A.
    Eur J Health Econ; 2009 Feb 01; 10(1):65-79. PubMed ID: 18437437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 80.